Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure

Molecular and Cellular Endocrinology

Volumn 398, Issue 1-2, 2014, Pages 101-113

  vom Saal, Frederick S ^a   Welshons, Wade V ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

A; Biomonitoring; Bisphenol; Contamination; Endocrine disrupting chemicals; Pharmacokinetics

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; PHENOL DERIVATIVE;

ANALYSIS; ANIMAL; BLOOD; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMAN; PROCEDURES; RISK ASSESSMENT; URINE;

ANIMALS; BENZHYDRYL COMPOUNDS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; PHENOLS; RISK ASSESSMENT;

EID: 84914158063     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.09.028     Document Type: Review

References (120)

1. Angle B.M., Do R.P., Ponzi D., Stahlhut R.W., Drury B.E., Nagel S.C., et al. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod. Toxicol 2013, 42:256-268.
2. Ashby J., Tinwell H., Haseman J. Lack of effects for low dose levels of bisphenol A (BPA) and diethylstilbestrol (DES) on the prostate gland of CF1 mice exposed in utero. Reg. Tox. Pharm 1999, 30:156-166.
3. Bearer C.F. How are children different from adults?. Environ. Health Perspect 1995, 103(Suppl. 6):7-12.
4. Bearer C.F. Environmental health hazards: how children are different from adults. Future Child 1995, 5:11-26.
5. Braun J.M., Kalkbrenner A.E., Calafat A.M., Bernert J.T., Ye X., Silva M.J., et al. Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ. Health Perspect 2011, 119:131-137.
6. Cagen S.Z., Waechter J.M., Dimond S.S., Breslin W.J., Butala J.H., Jekat F.W., et al. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Tox. Sci 1999, 11:15-29.
7. Calafat A.M., Needham L.L. What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data?. Environ. Health Perspect 2009, 117:1481-1485.
8. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect 2008, 116:39-44.
9. Calafat A.M., Koch H.M., Swan S.H., Hauser R., Goldman L.R., Lanphear B.P., et al. Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res 2013, 15:403.
10. Calhoun K.C., Padilla-Banks E., Jefferson W.N., Liu L., Gerrish K.E., Young S.L., et al. Bisphenol A exposure alters developmental gene expression in the fetal rhesus macaque uterus. PLoS ONE 2014, 9:e85894.
11. CERHR NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A (November 26, 2007) Center for the Evaluation of Risks to Human Reproduction, National Toxicology Program, National Institutes of Health, accessed 14.10.14. http://www.printpack.com/Repository/Files/NTP%20Expert%20Panel%20Report%20on%20BPA.pdf.
12. Chapalamadugu K.C., Vandevoort C.A., Settles M.L., Robison B.D., Murdoch G.K. Maternal bisphenol A exposure impacts the fetal heart transcriptome. PLoS ONE 2014, 9:e89096.
13. Churchwell M.I., Camacho L., Vanlandingham M.M., Twaddle N.C., Sepehr E., Delclos K.B., et al. Comparison of life-stage-dependent internal dosimetry for bisphenol A, ethinyl estradiol, a reference estrogen, and endogenous estradiol to test an estrogenic mode of action in Sprague Dawley rats. Toxicol. Sci 2014, 139:4-20.
14. Corbel T., Gayrard V., Viguie C., Puel S., Lacroix M.Z., Toutain P.L., et al. Bisphenol A disposition in the sheep maternal-placental-fetal unit: mechanisms determining fetal internal exposure. Biol. Reprod 2013, 89(1):11.
15. de Wildt S.N., Kearns G.L., Leeder J.S., van den Anker J.N. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin. Pharmacokinet 1999, 36:439-452.
16. Dekant W., Volkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol. Appl. Pharmacol 2008, 228:114-134.
17. Delclos K.B., Camacho L., Lewis S.M., Vanlandingham M.M., Latendresse J.R., Olson G.R., et al. Toxicity evaluation of bisphenol A administered by gavage to Sprague Dawley rats from gestation day 6 through postnatal day 90. Toxicol. Sci 2014, 139:174-197.
18. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol. Appl. Pharmacol 2010, 247:158-165.
19. Doerge D.R., Twaddle N.C., Woodling K.A., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol. Appl. Pharmacol 2010, 248:1-11.
20. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in serum and adipose tissue following intravenous administration to adult female CD-1 mice. Toxicol. Lett 2012, 211:114-119.
21. EDF, 1997. Toxic Ignorance: The Continuing Absence of Basic Health Testing for Top-selling Chemicals in the United States, Environmental Defense Fund, New York. New York.
22. EFSA Draft scientific opinion on the risks to public health related to the presence of bisphenol A (BPA). Foodstuffs - Exposure Assessment; EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 2013, European Food Safety Authority, July 1.
23. Ehrlich S., Calafat A.M., Humblet O., Smith T., Hauser R. Handling of thermal receipts as a source of exposure to bisphenol A. JAMA 2014, 311:859-860.
24. Elsworth J.D., Jentsch J.D., Vandevoort C.A., Roth R.H., Jr D.E., Leranth C. Prenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates. Neurotoxicology 2013, 35:113-120.
25. EnvironmentCanada, 2008. Screening Assessment for The Challenge Phenol, 4,4' -(1-methylethylidene)bis- (Bisphenol A) Chemical Abstracts Service Registry Number 80-05-7. Environment Canada and Health Canada, Ottawa, October 2008.
26. FDA Food and Drug Administration draft assessment of bisphenol A for use in Food contact applications, August 14, 2008 accessed 14.08.06. http://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm166145.htm.
27. FDA FDA Science Board Subcommittee Report on Bisphenol A accessed 14.08.13. http://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm166145.htm.
28. Fitzmaurice S., Maibach H.I. Gender differences in skin. Textbook of Aging Skin 2010, 999-1017. Springer, New York. M.A. Farage (Ed.).
29. Funke A.P., Schiller R., Motzkus H.W., Gunther C., Muller R.H., Lipp R. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations. Pharm. Res 2002, 19:661-668.
30. Gayrard V., Lacroix M.Z., Collet S.H., Viguie C., Bousquet-Melou A., Toutain P.L., et al. High bioavailability of bisphenol A from sublingual exposure. Environ. Health Perspect 2013, 121:951-956.
31. Gerona R.R., Woodruff T.J., Dickenson C.A., Pan J., Schwartz J.M., Sen S., et al. BPA, BPA glucuronide, and BPA sulfate in mid-gestation umbilical cord serum in a northern California cohort. Environ. Sci. Technol 2013, 47:12477-12485.
32. Gies A., Heinzow B., Dieter H.H., Heindel J. Bisphenol a workshop of the German Federal Environment Agency - March 30-31, 2009 work group report: public health issues of bisphenol A. Int. J. Hyg. Environ. Health 2009, 212:693-696.
33. GrandViewResearch Global bisphenol A (BPA) market by application (appliances, automotive, consumer, construction, electrical & electronics) expected to reach USD 20.03 billion by 2020 accessed 14.06.24. http://www.digitaljournal.com/pr/2009287.
34. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc. Soc. Exp. Biol. Med 2000, 224:61-68.
35. Gupta C. The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate differentiation. Urol. Res 2000, 28:223-229.
36. Hormann A.M., vom Saal F.S., Nagel S.C., Stahlhut R.W., Moyer C.L., Ellersieck M.R., et al. Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol A (BPA). Mol. Cell. Endocrinol 2014.
37. Hunt P.A., Lawson C., Gieske M., Murdoch B., Smith H., Marre A., et al. Bisphenol A alters early oogenesis and follicle formation in the fetal ovary of the rhesus monkey. Proc. Natl Acad. Sci. U.S.A. 2012, 109:17525-17530.
38. Hunt P.A., VandeVoort C., Woodruff T., Gerona R. Invalid controls undermine conclusions of FDA studies. Toxicol. Sci 2014, Online.
39. Inoue H., Tsuruta A., Kudo S., Ishii T., Fukushima Y., Iwano H., et al. Bisphenol A glucuronidation and excretion in liver of pregnant and nonpregnant female rats. Drug Metab. Dispos 2005, 33:55-59.
40. Inoue K., Kato K., Yoshimura Y., Makino T., Nakazawa H. Determination of bisphenol A in human serum by high-performance liquid chromatography with multi-electrode electrochemical detection. J. Chromatogr. B 2000, 749:17-23.
41. Karande P., Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim. Biophys. Acta 2009, 1788:2362-2373.
42. Koch H.M., Kolossa-Gehring M., Schroter-Kermani C., Angerer J., Bruning T. Bisphenol A in 24h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J. Expo. Sci. Environ. Epidemiol 2012, 22:610-616.
43. Kuroda N., Kinoshita Y., Sun Y., Wada M., Kishikawa N., Nakashima K., et al. Measurement of bisphenol A levels in human blood serum and ascitic fluid by HPLC using a fluorescent labeling reagent. J. Pharm. Biomed. Anal 2003, 30:1743-1749.
44. Lakind J.S., Naiman D.Q. Bisphenol A (BPA) daily intakes in the United States: estimates from the 2003-2004 NHANES urinary BPA data. J. Expo. Sci. Environ. Epidemiol 2008, 18:608-615.
45. LaKind J.S., Barraj L., Tran N., Aylward L.L. Environmental chemicals in people: challenges in interpreting biomonitoring information. J. Environ. Health 2008, 70:61-64.
46. Lee Y.J., Ryu H.Y., Kim H.K., Min C.S., Lee J.H., Kim E., et al. Maternal and fetal exposure to bisphenol A in Korea. Reprod. Toxicol 2008, 25:413-419.
47. Liao C., Kannan K. Widespread occurrence of bisphenol A in paper and paper products: implications for human exposure. Environ. Sci. Technol 2011, 45:9372-9739.
48. Liao C., Kannan K. Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ. Sci. Technol 2012, 46:5003-5009.
49. Markham D.A., Waechter J.M., Wimber M., Rao N., Connolly P., Chuang J.C., et al. Development of a method for the determination of bisphenol a at trace concentrations in human blood and urine and elucidation of factors influencing method accuracy and sensitivity. J. Anal. Toxicol 2010, 34:293-303.
50. Markowitz G., Rosner D. "Cater to the children": the role of the lead industry in a public health tragedy, 1900-1955. Am. J. Public Health 2000, 90:36-46.
51. Matsumoto J., Yokota H., Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ. Health Perspect 2002, 110:193-196.
52. Mendum T., Stoler E., VanBenschoten H., Warner J.C. Concentration of bisphenol A in thermal paper. Green Chem. Lett. Rev 2011, 4:81-86.
53. Michaels D., Monforton C. Manufacturing uncertainty: contested science and the protection of the public's health and environment. Am. J. Public Health 2005, 95(Suppl. 1):S39-S48.
54. Miyakoda H., Tabata M., Onodera S., Takeda K. Passage of bisphenol A into the fetus of the pregnant rat. J. Health Sci 1999, 45:318-323.
55. Montano M.M., Welshons W.V., vom Saal F.S. Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female rats. Biol. Reprod 1995, 53:1198-1207.
56. Myers J.P., vom Saal F.S., Akingbemi B.T., Arizono K., Belcher S., Colborn T., et al. Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ. Health Perspect 2009, 117:309-315.
57. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect 1997, 105:70-76.
58. Nagel S.C., vom Saal F.S., Welshons W.V. Developmental effects of estrogenic chemicals are predicted by an in vitro assay incorporating modification of cell uptake by serum. J. Steroid Biochem. Mol. Biol 1999, 69:343-357.
59. Narang N., Sharma J. Sublingual mucosa as a route for systemic drug delivery. Int. J. Pharm. Pharm. Sci 2011, 3(Suppl. 2):18-22.
60. NTP National toxicology program final report of the endocrine disruptors low dose peer review panel. Federal register: May 16, 2001 vol. 66. No. 95. p. 27152, accessed 14.09.01. http://ntp.niehs.nih.gov/index.cfm?objectid%26#x2009;=%26#x2009;06F4619A-0C57-9617-E21EEBE84FE72DD7.
61. Ong E.K., Glantz S.A. Constructing "sound science" and "good epidemiology": tobacco, lawyers, and public relations firms. Amer. J. Public Health 2001, 91:1749-1756.
62. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., et al. Maternal bisphenol-A levels at delivery: a looming problem?. J. Perinatol 2008, 28:258-263.
63. Patterson T.A., Twaddle N.C., Roegge C.S., Callicott R.J., Fisher J.W., Doerge D.R. Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys. Toxicol. Appl. Pharmacol 2013, 267:41-48.
64. Peretz J., Vrooman L., Ricke W.A., Hunt P.A., Ehrlich S., Hauser R., et al. Bisphenol A and reproductive health: update of experimental and human evidence, 2007-2013. Environ. Health Perspect 2014, 122:775-786.
65. Polak S., Ghobadi C., Mishra H., Ahamadi M., Patel N., Jamei M., et al. Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption. J. Pharm. Sci 2012, 101:2584-2595.
66. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci 2000, 54:3-18.
67. Prins G.S., Ye S.H., Birch L., Ho S.M., Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod. Toxicol 2011, 31:1-9.
68. Reif D.M., Martin M.T., Tan S.W., Houck K.A., Judson R.S., Richard A.M., et al. Endocrine profiling and prioritization of environmental chemicals using ToxCast data. Environ. Health Perspect 2010, 118:1714-1720.
69. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol 2007, 24:199-224.
70. Rochester J.R. Bisphenol A and human health: a review of the literature. Reprod. Toxicol 2013, 42:132-155.
71. Sajiki J., Takahashi K., Yonekubo J. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J. Chromatogr. B 1999, 736:255-261.
72. Salgueiro-Gonzalez N., Turnes-Carou I., Muniategui-Lorenzo S., Lopez-Mahia P., Prada-Rodriguez D. Fast and selective pressurized liquid extraction with simultaneous in cell clean up for the analysis of alkylphenols and bisphenol A in bivalve molluscs. J. Chromatogr. A 2012.
73. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in human maternal-fetal-placental unit. Environ. Health Perspect 2002, 110:A703-A707.
74. Sheehan D.M. Activity of environmentally relevant low doses of endocrine disruptors and the bisphenol A controversy: initial results confirmed. Proc. Soc. Exp. Biol. Med 2000, 224:57-60.
75. Sheehan D.M., Young M. Diethylstilbestrol and estradiol binding to serum albumin and pregnancy plasma of rats and humans. Endocrinol 1979, 104:1442-1446.
76. Singh I., Morris A.P. Performance of transdermal therapeutic systems: effects of biological factors. Int. J. Pharm. Investig 2011, 1:4-9.
77. Soto A.M., Brisken C., Schaeberle C., Sonnenschein C. Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J. Mammary Gland Biol. Neoplasia 2013, 18:199-208.
78. Sprague B.L., Trentham-Dietz A., Hedman C.J., Wang J., Hemming J.D., Hampton J.M., et al. Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res 2013, 15:R45.
79. Sprague B.L., Trentham-Dietz A., Hedman C.J., Wang J., Hemming J.D., Hampton J.M., et al. Authors' response. Breast Cancer Res 2013, 15:403.
80. Stahlhut R.W., Welshons W.V., Swan S.H. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect 2009, 117:784-789.
81. Steinmetz R., Brown N.G., Allen D.L., Bigsby R.M., Ben-Jonathan N. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 1997, 138:1780-1786.
82. Tan B.L.L., Mohd M.A. Analysis of selected pesticides and alkylphenols in human cord blood by gas chromatograph-mass spectrometer. Talanta 2003, 61:385-391.
83. Taylor J.A., Welshons W.V., Vom Saal F.S. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice. Reprod. Toxicol 2008, 25:169-176.
84. Taylor J.A., Vom Saal F.S., Welshons W.V., Drury B., Rottinghaus G., Hunt P.A., et al. Similarity of bisphenol a pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect 2011, 119:422-430.
85. Teeguarden J.G., Calafat A.M., Ye X., Doerge D.R., Churchwell M.I., Gunawan R., et al. Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol. Sci 2011, 123:48-57.
86. Tharp A.P., Maffini M.V., Hunt P.A., VandeVoort C.A., Sonnenschein C., Soto A.M. Bisphenol A alters the development of the rhesus monkey mammary gland. Proc. Natl Acad. Sci. U.S.A. 2012, 109:8190-8195.
87. Trasande L. Further limiting bisphenol A in food uses could provide health and economic benefits. Health Aff. (Millwood) 2014, 33:316-323.
88. Twaddle N.C., Churchwell M.I., Vanlandingham M., Doerge D.R. Quantification of deuterated bisphenol A in serum, tissues, and excreta from adult Sprague-Dawley rats using liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom 2010, 24:3011-3020.
89. vom Saal F.S., Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect 2005, 113:926-933.
90. vom Saal F.S., Myers J.P. Good laboratory practices are not synonymous with good scientific practices, accurate reporting, or valid data. Environ. Health Perspect 2010, 118:A60.
91. vom Saal F.S., Sheehan D.M. Challenging risk assessment. Forum Appl. Res. Public Policy 1998, 13:11-18.
92. vom Saal F.S., Welshons W.V. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ. Res 2006, 100:50-76.
93. vom Saal F.S., Quadagno D.M., Even M.D., Keisler L.W., Keisler D.H., Khan S. Paradoxical effects of maternal stress on fetal steroids and postnatal reproductive traits in female mice from different intrauterine positions. Biol. Reprod 1990, 43:751-761.
94. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. PNAS 1997, 94:2056-2061.
95. vom Saal F.S., Cooke P.S., Buchanan D.L., Palanza P., Thayer K.A., Nagel S.C., et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol. Ind. Health 1998, 14:239-260.
96. vom Saal F.S., Akingbemi B.T., Belcher S.M., Birnbaum L.S., Crain D.A., Eriksen M., et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol 2007, 24:131-138.
97. vom Saal F.S., Akingbemi B.T., Belcher S.M., Crain D.A., Crews D., Guidice L.C., et al. Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol. Sci 2010, 115:612-613.
98. vom Saal F.S., Vandevoort C.A., Taylor J.A., Welshons W.V., Toutain P.L., Hunt P.A. Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: relevance for human exposures. Reprod. Toxicol 2014, 45:105-116.
99. Van Winkle L.S., Murphy S.R., Boetticher M.V., Vandevoort C.A. Fetal exposure of rhesus macaques to bisphenol A alters cellular development of the conducting airway by changing epithelial secretory product expression. Environ. Health Perspect 2013, 121:912-918.
100. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod. Toxicol 2007, 24:139-177.
101. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect 2010, 118:1055-1070.
102. Vandenberg L.N., Chahoud I., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ. Health Perspect 2010, 118:1051-1054.
103. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev 2012, 33:378-455.
104. Vandenberg L.N., Ehrlich S., Belcher S.M., Ben-Jonathan N., Dolinoy D.C., Hugo E.S., et al. Low dose effects of bisphenol A: an integrated review of in vitro, laboratory animal and epidemiology studies. Endocr. Disrupt 2013, 1:E1-E20.
105. Vandenberg L.N., Hunt P.A., Myers J.P., Vom Saal F.S. Human exposures to bisphenol A: mismatches between data and assumptions. Rev. Environ. Health 2013, 28:37-58.
106. Vandenberg L.N., Gerona R.R., Kannan K., Taylor J.A., van Breemen R.B., Dickenson C.A., et al. A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ. Health 2014, 13:25.
107. Vandenberg L.N., Welshons W.V., Vom Saal F.S., Toutain P.L., Myers J.P. Should oral gavage be abandoned in toxicity testing of endocrine disruptors?. Environ. Health 2014, 13:46.
108. Vandentorren S., Zeman F., Morin L., Sarter H., Bidondo M.L., Oleko A., et al. Bisphenol-A and phthalates contamination of urine samples by catheters in the Elfe pilot study: implications for large-scale biomonitoring studies. Environ. Res 2011, 111:761-764.
109. Vanderford B.J., Drewes J.E., Eaton A., Guo Y.C., Haghani A., Hoppe-Jones C., et al. Results of an interlaboratory comparison of analytical methods for contaminants of emerging concern in water. Anal. Chem 2014, 86:774-782.
110. Viñas R., Goldblum R.W., Watson C.S. Rapid estrogenic signaling activities of the modified (chlorinated, sulfonated, and glucuronidated) endocrine disruptor bisphenol A. Endocr. Disrupt 2013, 1(1):e25411.
111. Volkel W., Colnot T., Csanady G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem. Res. Toxicol 2002, 15:1281-1287.
112. Watabe Y., Kondo T., Imai H., Morita M., Tanaka N., Hosoya K. Reducing bisphenol A contamination from analytical procedures to determine ultralow levels in environmental samples using automated HPLC microanalysis. Anal. Chem 2004, 76:105-109.
113. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect 2003, 111:994-1006.
114. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinol 2006, 147:S56-S69.
115. Wetherill Y.B., Akingbemi B.T., Kanno J., McLachlan J.A., Nadal A., Sonnenschein C., et al. In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol 2007, 24:178-198.
116. Ye X., Zhou X., Hennings R., Kramer J., Calafat A.M. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ. Health Perspect 2013, 121:283-286.
117. Yoshimura Y., Brock J.W., Makino T., Nakazawa H. Measurement of bisphenol A in human serum by gas chromatography/mass spectrometry. Anal. Chim. Acta 2002, 458:331-336.
118. Zalko D., Soto A.M., Dolo L., Dorio C., Rathahao E., Debrauwer L., et al. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ. Health Perspect 2003, 111:309-319.
119. Zalko D., Jacques C., Duplan H., Bruel S., Perdu E. Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere 2011, 82:424-430.
120. Zoeller R.T., Brown T.R., Doan L.L., Gore A.C., Skakkebaek N.E., Soto A.M., et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the endocrine society. Endocrinology 2012, 153:4097-4110.